{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:24:48Z","timestamp":1768343088200,"version":"3.49.0"},"reference-count":74,"publisher":"Oncology Nursing Society (ONS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1188\/20.onf.e211-e224","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T06:48:46Z","timestamp":1602830926000},"page":"E211-E224","source":"Crossref","is-referenced-by-count":11,"title":["Management of Opioid-Induced and Non\u2013Opioid-Related Constipation in Patients With Cancer: Systematic Review and Meta-Analysis"],"prefix":"10.1188","volume":"47","author":[{"given":"Pamela","family":"Ginex","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"LeFebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Vrabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Amankwah, J., Winn, S., Akins, L., Diaz, D., Thirlwell, S., & Wagnerowski, M. (2015). Constipation and opioids: Creation and adoption of evidence-based patient education tool [Abstract]. Oncology Nursing Forum, 42(2), E110\u2013E249. https:\/\/doi.org\/10.1188\/15.ONF.E110","DOI":"10.1188\/15.ONF.E110"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Benyamin, R., Trescot, A.M., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., . . . Vallejo, R. (2008). Opioid complications and side effects. Pain Physician, 11(Suppl. 2), S105\u2013S120.","DOI":"10.36076\/ppj.2008\/11\/S105"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bharucha, A.E., Pemberton, J.H., & Locke, G.R., 3rd. (2013). American Gastroenterological Association technical review on constipation. Gastroenterology, 144(1), 218\u2013238. https:\/\/doi.org\/10.1053\/j.gastro.2012.10.028","DOI":"10.1053\/j.gastro.2012.10.028"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bull, J., Wellman, C.V., Israel, R.J., Barrett, A.C., Paterson, C., & Forbes, W.P. (2015). Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: Results of a randomized, placebo-controlled study and open-label extension.\u00a0Journal of Palliative Medicine,\u00a018(7), 593\u2013600. https:\/\/doi.org\/10.1089\/jpm.2014.0362","DOI":"10.1089\/jpm.2014.0362"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Camilleri, M., Drossman, D.A., Becker, G., Webster, L.R., Davies, A.N., & Maw, G.M. (2014). Emerging treatments in neurogastroenterology: A multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterology and Motility, 26(10), 1386\u20131395. https:\/\/doi.org\/10.1111\/nmo.12417","DOI":"10.1111\/nmo.12417"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chey, W.D., Webster, L., Sostek, M., Lappalainen, J., Barker, P.N., & Tack, J. (2014). Naloxegol for opioid-induced constipation in patients with noncancer pain.\u00a0New England Journal of Medicine, 370(25), 2387\u20132396. https:\/\/doi.org\/10.1056\/NEJMoa1310246","DOI":"10.1056\/NEJMoa1310246"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Clemens, K.E., Faust, M., Jaspers, B., & Mikus, G. (2013). Pharmacological treatment of constipation in palliative care. Current Opinion in Supportive and Palliative Care, 7(2), 183\u2013191. https:\/\/doi.org\/10.1097\/SPC.0b013e32835f1e17","DOI":"10.1097\/SPC.0b013e32835f1e17"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Costilla, V.C., & Foxx-Orenstein, A.E. (2014). Constipation: Understanding mechanisms and management. Clinics in Geriatric Medicine, 30(1), 107\u2013115. https:\/\/doi.org\/10.1016\/j.cger.2013.10.001","DOI":"10.1016\/j.cger.2013.10.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Cryer, B., Katz, S., Vallejo, R., Popescu, A., & Ueno, R. (2014). A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.\u00a0Pain Medicine,\u00a015(11), 1825\u20131834. https:\/\/doi.org\/10.1111\/pme.12437","DOI":"10.1111\/pme.12437"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Da, N., Wang, X., Liu, H., Xu, X., Jin, X., Chen, C., . . . Zhang, J. (2015). The effectiveness of electroacupuncture for functional constipation: A randomized, controlled, clinical trial.\u00a0Evidence-Based Complementary and Alternative Medicine,\u00a02015, 670963. https:\/\/doi.org\/10.1155\/2015\/670963","DOI":"10.1155\/2015\/670963"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Davies, A., Leach, C., Caponero, R., Dickman, A., Fuchs, D., Paice, J., & Emmanuel, A. (2020). MASCC recommendations on the management of constipation in patients with advanced cancer.\u00a0Supportive Care in Cancer, 28(1), 23\u201333. https:\/\/doi.org\/10.1007\/s00520-019-05016-4","DOI":"10.1007\/s00520-019-05016-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Downing, G.M., Kuziemsky, C., Lesperance, M., Lau, F., & Syme, A. (2007). Development and reliability testing of the Victoria Bowel Performance Scale (BPS). Journal of Pain and Symptom Management, 34(5), 513\u2013522. https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.01.014","DOI":"10.1016\/j.jpainsymman.2007.01.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ford, A.C., & Suares, N.C. (2011). Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: Systematic review and meta-analysis. Gut, 60(2), 209\u2013218. https:\/\/doi.org\/10.1136\/gut.2010.227132","DOI":"10.1136\/gut.2010.227132"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Forootan, M., Bagheri, N., & Darvishi, M. (2018). Chronic constipation: A review of literature. Medicine, 97(20), e10631. https:\/\/doi.org\/10.1097\/MD.0000000000010631","DOI":"10.1097\/MD.0000000000010631"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Freedman, M.D., Schwartz, H.J., Roby, R., & Fleisher, S. (1997). Tolerance and efficacy of polyethylene glycol 3350\/electrolyte solution versus lactulose in relieving opiate induced constipation: A double-blinded placebo-controlled trial.\u00a0Journal of Clinical Pharmacology,\u00a037(10), 904\u2013907. https:\/\/doi.org\/10.1002\/j.1552-4604.1997.tb04264.x","DOI":"10.1002\/j.1552-4604.1997.tb04264.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Gaertner, J., Siemens, W., Camilleri, M., Davies, A., Drossman, D.A., Webster, L.R., & Becker, G. (2015). Definitions and outcome measures of clinical trials regarding opioid-induced constipation: A systematic review.\u00a0Journal of Clinical Gastroenterology,\u00a049(1), 9\u201316. https:\/\/doi.org\/10.1097\/MCG.0000000000000246","DOI":"10.1097\/MCG.0000000000000246"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Guyatt, G., Oxman, A.D., Akl, E.A., Kunz, R., Vist, G., Brozek, J., . . . Sch\u00fcnemann, H.J. (2011). GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables.\u00a0Journal of Clinical Epidemiology,\u00a064(4), 383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Hale, M., Wild, J., Reddy, J., Yamada, T., & Ferreira, J.C.A. (2017). Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): Two multicentre, phase 3, double-blind, randomised, parallel-group trials.\u00a0Lancet Gastroenterology and Hepatology,\u00a02(8), 555\u2013564. https:\/\/doi.org\/10.1016\/S2468-1253(17)30105-X","DOI":"10.1016\/S2468-1253(17)30105-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hanai, A., Ishiguro, H., Sozu, T., Tsuda, M., Arai, H., Mitani, A., & Tsuboyama, T. (2016). Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: A randomized controlled clinical trial.\u00a0Breast Cancer Research and Treatment,\u00a0155(1), 99\u2013107. https:\/\/doi.org\/10.1007\/s10549-015-3652-4","DOI":"10.1007\/s10549-015-3652-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hanson, B., Siddique, S.M., Scarlett, Y., & Sultan, S. (2019). American Gastroenterological Association Institute technical review on the medical management of opioid-induced constipation. Gastroenterology, 156(1), 229\u2013253. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.018","DOI":"10.1053\/j.gastro.2018.08.018"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Altman, D.G., G\u00f8tzsche, P.C., J\u00fcni, P., Moher, D., Oxman, A.D., . . . Sterne, J.A.C. (2011). The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ, 343, d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","DOI":"10.1136\/bmj.d5928"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Jamal, M.M., Adams, A.B., Jansen, J.-P., & Webster, L.R. (2015). A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.\u00a0American Journal of Gastroenterology,\u00a0110(5), 725\u2013732. https:\/\/doi.org\/10.1038\/ajg.2015.106","DOI":"10.1038\/ajg.2015.106"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Katakami, N., Harada, T., Murata, T., Shinozaki, K., Tsutsumi, M., Yokota, T., . . . Boku, N. (2017). Randomized phase III and extension studies of naldemedine in patients with opioid-induced constipation and cancer.\u00a0Journal of Clinical Oncology,\u00a035(34), 3859\u20133866. https:\/\/doi.org\/10.1200\/JCO.2017.73.0853","DOI":"10.1200\/JCO.2017.73.0853"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Katakami, N., Harada, T., Murata, T., Shinozaki, K., Tsutsumi, M., Yokota, T., . . . Boku, N. (2018). Randomized phase III and extension studies: Efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Annals of Oncology, 29(6), 1461\u20131467. https:\/\/doi.org\/10.1093\/annonc\/mdy118","DOI":"10.1093\/annonc\/mdy118"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Katakami, N., Oda, K., Tauchi, K., Nakata, K., Shinozaki, K., Yokota, T., . . . Boku, N. (2017). Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer.\u00a0Journal of Clinical Oncology,\u00a035(17), 1921\u20131928. https:\/\/doi.org\/10.1200\/JCO.2016.70.8453","DOI":"10.1200\/JCO.2016.70.8453"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Kaur, V., Haider, S., Sasapu, A., Mehta, P., Arnaooutakis, K., & Makhoul, I. (2016). Addressing opioid-associated constipation using quality oncology practice initiative scores and Plan-Do-Study-Act cycles. Journal of Oncology Practice, 13(1), e91\u2013e97. https:\/\/doi.org\/10.1200\/JOP.2016.013797","DOI":"10.1200\/JOP.2016.013797"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Lacy, B.E., Schey, R., Shiff, S.J., Lavins, B.J., Fox, S.M., Jia, X.D., . . . Lembo, A.J. (2015). Linaclotide in chronic idiopathic constipation patients with moderate to severe abdominal bloating: A randomized, controlled trial.\u00a0PLOS ONE, 10(7), e0134349. https:\/\/doi.org\/10.1371\/journal.pone.0134349","DOI":"10.1371\/journal.pone.0134349"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Larkin, P.J., Cherny, N.I., La Carpia, D., Guglielmo, M., Ostgathe, C., Scott\u00e9, F., & Ripamonti, C.I. (2018). Diagnosis, assessment and management of constipation in advanced cancer: ESMO clinical practice guidelines.\u00a0Annals of Oncology,\u00a029(Suppl. 4), iv111\u2013iv125. https:\/\/doi.org\/10.1093\/annonc\/mdy148","DOI":"10.1093\/annonc\/mdy148"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Lee, H.-Y., Kwon, O.-J., Kim, J.-E., Kim, M., Kim, A.-R., Park, H.-J., . . . Choi, S.-M. (2018). Efficacy and safety of acupuncture for functional constipation: A randomised, sham-controlled pilot trial.\u00a0BMC Complementary and Alternative Medicine,\u00a018(1), 186. https:\/\/doi.org\/10.1186\/s12906-018-2243-4","DOI":"10.1186\/s12906-018-2243-4"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Lembo, A.J., Kurtz, C.B., MacDougall, J.E., Lavins, B.J., Currie, M.G., Fitch, D.A., . . . Johnston, J.M. (2010). Efficacy of linaclotide for patients with chronic constipation.\u00a0Gastroenterology,\u00a0138(3), 886\u2013895. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.050","DOI":"10.1053\/j.gastro.2009.12.050"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Lembo, A.J., Schneier, H.A., Shiff, S.J., Kurtz, C.B., MacDougall, J.E., Jia, X.D., . . . Johnston, J.M. (2011). Two randomized trials of linaclotide for chronic constipation.\u00a0New England Journal of Medicine,\u00a0365(6), 527\u2013536. https:\/\/doi.org\/10.1056\/NEJMoa1010863\u00a0","DOI":"10.1056\/NEJMoa1010863"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Liu, Y.-Q., Sun, S., Dong, H.-J., Zhai, D.-X., Zhang, D.-Y., Shen, W., . . . Yu, C.-Q. (2015). Wrist-ankle acupuncture and ginger moxibustion for preventing gastrointestinal reactions to chemotherapy: A randomized controlled trial.\u00a0Chinese Journal of Integrative Medicine,\u00a021(9), 697\u2013702. https:\/\/doi.org\/10.1007\/s11655-014-2009-x","DOI":"10.1007\/s11655-014-2009-x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Liu, Z., Yan, S., Wu, J., He, L., Li, N., Dong, G., . . . Liu, B. (2016). Acupuncture for chronic severe functional constipation: A randomized trial.\u00a0Annals of Internal Medicine,\u00a0165(11), 761\u2013769. https:\/\/doi.org\/10.7326\/M15-3118","DOI":"10.7326\/M15-3118"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Mari, A., Mahamid, M., Amara, H., Baker, F.A., & Yaccob, A. (2020). Chronic constipation in the elderly patient: Updates in evaluation and management. Korean Journal of Family Medicine, 41(3), 139\u2013145. https:\/\/doi.org\/10.4082\/kjfm.18.0182","DOI":"10.4082\/kjfm.18.0182"},{"key":"36","unstructured":"Martin, B.C., Barghout, V., & Cerulli, A. (2006). Direct medical costs of constipation in the United States. Managed Care Interface, 19(12), 43\u201349."},{"key":"37","unstructured":"McCormick, D. (2019). Managing costs and care for chronic idiopathic constipation. American Journal of Managed Care, 25(4, Suppl.), S63\u2013S69."},{"key":"38","doi-asserted-by":"crossref","unstructured":"McGraw, T. (2016). Safety of polyethylene glycol 3350 solution in chronic constipation: Randomized, placebo-controlled trial.\u00a0Clinical and Experimental Gastroenterology,\u00a09, 173\u2013180. https:\/\/doi.org\/10.2147\/CEG.S111693","DOI":"10.2147\/CEG.S111693"},{"key":"39","doi-asserted-by":"crossref","unstructured":"McMillan, S.C. (2004). Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control, 11(3, Suppl.), 3\u20139. https:\/\/doi.org\/10.1177\/10732748040110S302","DOI":"10.1177\/10732748040110S302"},{"key":"40","doi-asserted-by":"crossref","unstructured":"McMillan, S.C., Tofthagen, C., Small, B., Karver, S., & Craig, D. (2013). Trajectory of medication-induced constipation in patients with cancer. Oncology Nursing Forum, 40(3), E92\u2013E100. https:\/\/doi.org\/10.1188\/13.ONF.E92-E100","DOI":"10.1188\/13.ONF.E92-E100"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Mearin, F., Lacy, B.E., Chang, L., Chey, W.D., Lembo, A.J., Simren, M., & Spiller, R. (2016). Bowel disorders. Gastroenterology, 150(6), 1393\u20131407. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","DOI":"10.1053\/j.gastro.2016.02.031"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Michna, E., Blonsky, E.R., Schulman, S., Tzanis, E., Manley, A., Zhang, H., . . . Randazzo, B. (2011). Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: A randomized controlled study.\u00a0Journal of Pain,\u00a012(5), 554\u2013562. https:\/\/doi.org\/10.1016\/j.jpain.2010.11.008","DOI":"10.1016\/j.jpain.2010.11.008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., & Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, PLOS Medicine, 6(7), e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","DOI":"10.1371\/journal.pmed.1000097"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Mori, T., Shibasaki, Y., Matsumoto, K., Shibasaki, M., Hasegawa, M., Wang, E., . . . Suzuki, T. (2013). Mechanisms that underlie \u03bc-opioid receptor agonist\u2013induced constipation: Differential involvement of \u03bc-opioid receptor sites and responsible regions.\u00a0Journal of Pharmacology and Experimental Therapeutics,\u00a0347(1), 91\u201399. https:\/\/doi.org\/10.1124\/jpet.113.204313","DOI":"10.1124\/jpet.113.204313"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Nakajima, A., Shinbo, K., Oota, A., & Kinoshita, Y. (2019). Polyethylene glycol 3350 plus electrolytes for chronic constipation: A 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension.\u00a0Journal of Gastroenterology,\u00a054(9), 792\u2013803. https:\/\/doi.org\/10.1007\/s00535-019-01581-x","DOI":"10.1007\/s00535-019-01581-x"},{"key":"46","unstructured":"National Comprehensive Cancer Network. (2020). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Palliative care [v.1.2020]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/palliative.pdf"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Nelson, A.D., Camilleri, M., Chirapongsathorn, S., Vijayvargiya, P., Valentin, N., Shin, A., . . . Murad, M.H. (2017). Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: A systematic review and network meta-analysis. Gut, 66(9), 1611\u20131622. https:\/\/doi.org\/10.1136\/gutjnl-2016-311835","DOI":"10.1136\/gutjnl-2016-311835"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Par\u00e9, P., & Fedorak, R.N. (2014). Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation. Canadian Journal of Gastroenterology and Hepatology, 28(10), 549\u2013557. https:\/\/doi.org\/10.1155\/2014\/631740","DOI":"10.1155\/2014\/631740"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Portenoy, R.K., Thomas, J., Boatwright, M.L.M., Tran, D., Galasso, F.L., Stambler, N., . . . Israel, R.J. (2008). Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: A double-blind, randomized, parallel group, dose-ranging study.\u00a0Journal of Pain and Symptom Management,\u00a035(5), 458\u2013468. https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.12.005","DOI":"10.1016\/j.jpainsymman.2007.12.005"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Rauck, R., Slatkin, N.E., Stambler, N., Harper, J.R., & Israel, R.J. (2017). Randomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer pain.\u00a0Pain Practice,\u00a017(6), 820\u2013828. https:\/\/doi.org\/10.1111\/papr.12535","DOI":"10.1111\/papr.12535"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Rauck, R.L., Slatkin, N.E., Stambler, N., & Israel, R.J. (2019). Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.\u00a0Journal of Pain Research, 12, 139\u2013150. https:\/\/doi.org\/10.2147\/JPR.S170086","DOI":"10.2147\/JPR.S170086"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Reville, B., Axelrod, D., & Maury, R. (2009). Palliative care for the cancer patient. Primary Care, 36(4), 781\u2013810. https:\/\/doi.org\/10.1016\/j.pop.2009.07.010","DOI":"10.1016\/j.pop.2009.07.010"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Rhondali, W., Nguyen, L., Palmer, L., Kang, D.H., Hui, D., & Bruera, E. (2013). Self-reported constipation in patients with advanced cancer: A preliminary report. Journal of Pain and Symptom Management, 45(1), 23\u201332. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.01.009","DOI":"10.1016\/j.jpainsymman.2012.01.009"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Rithirangsriroj, K., Manchana, T., & Akkayagorn, L. (2015). Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecologic Oncology, 136(1), 82\u201386. https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.025","DOI":"10.1016\/j.ygyno.2014.10.025"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Shea, B.J., Reeves, B.C., Wells, G., Thuku, M., Hamel, C., Moran, J., . . . Henry, D.A. (2017). AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, j4008. https:\/\/doi.org\/10.1136\/bmj.j4008","DOI":"10.1136\/bmj.j4008"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Shen, Q., Zhu, H., Jiang, G., & Liu, X. (2018). Nurse-led self-management educational intervention improves symptoms of patients with functional constipation.\u00a0Western Journal of Nursing Research,\u00a040(6), 874\u2013888. https:\/\/doi.org\/10.1177\/0193945917701128","DOI":"10.1177\/0193945917701128"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Shin, J., & Park, H. (2018). Effects of auricular acupressure on constipation in patients with breast cancer receiving chemotherapy: A randomized control trial.\u00a0Western Journal of Nursing Research,\u00a040(1), 67\u201383. https:\/\/doi.org\/10.1177\/0193945916680362","DOI":"10.1177\/0193945916680362"},{"key":"58","unstructured":"Slatkin, N., Thomas, J., Lipman, A.G., Wilson, G., Boatwright, M.L., Wellman, C., . . . Israel, R. (2009). Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.\u00a0 Journal of Supportive Oncology,\u00a07(1), 39\u201346."},{"key":"59","doi-asserted-by":"crossref","unstructured":"Sloots, C.E.J., Rykx, A., Cools, M., Kerstens, R., & De Pauw, M. (2010). Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.\u00a0Digestive Diseases and Sciences,\u00a055(10), 2912\u20132921. https:\/\/doi.org\/10.1007\/s10620-010-1229-y","DOI":"10.1007\/s10620-010-1229-y"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Speed, C., Heaven, B., Adamson, A., Bond, J., Corbett, S., Lake, A.A., . . . McColl, E. (2010). LIFELAX-diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: Randomised controlled trial.\u00a0Health Technology Assessment, 14(52), 1\u2013251. https:\/\/doi.org\/10.3310\/hta14520","DOI":"10.3310\/hta14520"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Spierings, E.L.H., Rauck, R., Brewer, R., Marcuard, S., & Vallejo, R. (2016). Long-term safety and efficacy of lubiprostone in opioid-induced constipation in patients with chronic noncancer pain.\u00a0Pain Practice,\u00a016(8), 985\u2013993. https:\/\/doi.org\/10.1111\/papr.12347","DOI":"10.1111\/papr.12347"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Tarumi, Y., Wilson, M.P., Szafran, O., & Spooner, G.R. (2013). Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients.\u00a0Journal of Pain and Symptom Management,\u00a045(1), 2\u201313. https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.02.008","DOI":"10.1016\/j.jpainsymman.2012.02.008"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Thomas, J., Karver, S., Cooney, G.A., Chamberlain, B.H., Watt, C.K., Slatkin, N.E., . . . Israel, R J. (2008). Methylnaltrexone for opioid-induced constipation in advanced illness.\u00a0New England Journal of Medicine,\u00a0358(22), 2332\u20132343. https:\/\/doi.org\/10.1056\/NEJMoa0707377","DOI":"10.1056\/NEJMoa0707377"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Tomich, J.L., & Sipe, M.H. (2019). Fostering best practices for reducing opioid-induced constipation using technology. Computers, Informatics, Nursing, 37(11), 551\u2013557. https:\/\/doi.org\/10.1097\/CIN.0000000000000598","DOI":"10.1097\/CIN.0000000000000598"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Webster, L., Chey, W.D., Tack, J., Lappalainen, J., Diva, U., & Sostek, M. (2014). Randomized clinical trial: The long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.\u00a0Alimentary Pharmacology and Therapeutics,\u00a040(7), 771\u2013779. https:\/\/doi.org\/10.1111\/apt.12899","DOI":"10.1111\/apt.12899"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Webster, L., Dhar, S., Eldon, M., Masuoka, L., Lappalainen, J., & Sostek, M. (2013). A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation.\u00a0Pain, 154(9), 1542\u20131550. https:\/\/doi.org\/10.1016\/j.pain.2013.04.024","DOI":"10.1016\/j.pain.2013.04.024"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Webster, L., Diva, U., Tummala, R., & Sostek, M. (2018). Treatment with naloxegol versus placebo: Pain assessment in patients with noncancer pain and opioid-induced constipation.\u00a0Pain Practice,\u00a018(4), 505\u2013514. https:\/\/doi.org\/10.1111\/papr.12640","DOI":"10.1111\/papr.12640"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Webster, L.R., Brewer, R.P., Lichtlen, P., Losch-Beridon, T., Mareya, S., & Wang, M. (2018). Efficacy of lubiprostone for the treatment of opioid-induced constipation, analyzed by opioid class.\u00a0Pain Medicine,\u00a019(6), 1195\u20131205. https:\/\/doi.org\/10.1093\/pm\/pnx212","DOI":"10.1093\/pm\/pnx212"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Webster, L.R., & Israel, R.J. (2018). Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone.\u00a0Journal of Pain Research, 11, 2509\u20132516. https:\/\/doi.org\/10.2147\/JPR.S160625","DOI":"10.2147\/JPR.S160625"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Webster, L.R., Nalamachu, S., Morlion, B., Reddy, J., Baba, Y., Yamada, T., & Ferreira, J.C.A. (2018). Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: A randomized, double-blind, placebo-controlled phase 3 study.\u00a0Pain,\u00a0159(5), 987\u2013994. https:\/\/doi.org\/10.1097\/j.pain.0000000000001174","DOI":"10.1097\/j.pain.0000000000001174"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Webster, L.R., Yamada, T., & Ferreira, J.C.A. (2017). A phase 2b, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of naldemedine for the treatment of opioid-induced constipation in patients with chronic noncancer pain.\u00a0Pain Medicine,\u00a018(12), 2350\u20132360. https:\/\/doi.org\/10.1093\/pm\/pnw325","DOI":"10.1093\/pm\/pnw325"},{"key":"72","doi-asserted-by":"crossref","unstructured":"Wu, J., Liu, B., Li, N., Sun, J., Wang, L., Wang, L., . . . Liu, Z. (2014). Effect and safety of deep needling and shallow needling for functional constipation: A multicenter, randomized controlled trial.\u00a0Medicine,\u00a093(28), e284. https:\/\/doi.org\/10.1097\/MD.0000000000000284","DOI":"10.1097\/MD.0000000000000284"},{"key":"73","doi-asserted-by":"crossref","unstructured":"Wu, X., Zheng, C., Xu, X., Ding, P., Xiong, F., Tian, M., . . . Huang, G. (2017). Electroacupuncture for functional constipation: A multicenter, randomized, control trial.\u00a0Evidence-Based Complementary and Alternative Medicine,\u00a02017, 1428943. https:\/\/doi.org\/10.1155\/2017\/1428943","DOI":"10.1155\/2017\/1428943"},{"key":"74","doi-asserted-by":"crossref","unstructured":"Zheng, H., Liu, Z.S., Zhang, W., Chen, M., Zhong, F., Jing, X.H., . . . Zhu, B. (2018). Acupuncture for patients with chronic functional constipation: A randomized controlled trial.\u00a0Neurogastroenterology and Motility,\u00a030(7), e13307. https:\/\/doi.org\/10.1111\/nmo.13307","DOI":"10.1111\/nmo.13307"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/47\/6\/management-opioid-induced-and-non-opioid-related-constipation-patients-cancer-systematic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:58Z","timestamp":1763754598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/47\/6\/management-opioid-induced-and-non-opioid-related-constipation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1188\/20.onf.e211-e224","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}